总时间（秒）：16.49
问答时间（秒）：14.56

<think>
Okay, let's tackle this query. The user wants me to extract information from the provided abstract about Parkinson's disease (PD) related to PINK1 and parkin mutations. They need it structured in a specific JSON format with HGVS nomenclature and MONDO disease terms.

First, I'll read through the abstract carefully. The main points are about mutations in PINK1 and parkin causing autosomal recessive PD. The study shows that PINK1 phosphorylates parkin, activating its E3 ubiquitin ligase function, which is involved in the NF-kB pathway. Pathogenic mutations impair this process.

Now, for the variants. The abstract mentions "PD-linked pathogenic PINK1 mutations" but doesn't specify the exact mutations. However, in the introduction, it says that homozygous mutations in PINK1 are the second most common cause of early-onset recessive PD. But the exact HGVS nomenclature isn't given here. Since the user wants HGVS standardized via API, but the original text doesn't provide specific variants, I'll have to note that as N.D. for the variants. The gene is PINK1, so that's clear.

Next, the disease. The study is about Parkinson disease. The MONDO term for Parkinson's is MONDO:0005117. I'll check that. The abstract mentions "Parkinson disease (PD)" and "autosomal recessive forms of Parkinson disease (PD)", so the disease is PD, and the MONDO term is correct.

For the experimental methods, the abstract talks about PINK1 regulating parkin's function through phosphorylation. The methods mentioned are likely Western Blot or other assays to measure ubiquitination and NF-kB signaling. The study uses in vitro experiments, maybe with cell lines. The abstract doesn't specify the exact methods, so I'll use "Western Blot" as an example, but the user might need more details. However, since the literature doesn't mention specific methods, I'll have to use N.D. for the assay method. The material used is probably cell lines, like HEK293, but the abstract doesn't mention that. So, Material Source would be N.D. and Material Name is N.D. The readout type is qualitative or quantitative, but the abstract doesn't specify. So, Readout type is N.D. 

The Readout description needs to include all variants, but there are none. So, it's N.D. for that. The replicates, controls, etc., are not mentioned in the abstract, so they are all N.D. except for the approved assay, which is probably yes if the method is standard for PD studies. But since the abstract doesn't detail the methods, maybe it's N.D.

Putting it all together, the Variants Include will have PINK1 with no specific variants, so N.D. The Described Disease is Parkinson disease, MONDO:0005117. The Experiment Method section will have the assay method as "Western Blot" if that's a standard method, but the abstract doesn't specify. Alternatively, since the study is about phosphorylation and ubiquitination, maybe the methods include Western blot for protein expression and activity assays. But the user's example used Western Blot, so maybe that's acceptable. However, the literature doesn't mention specific methods, so I'll have to use N.D. for Assay Method. 

Wait, the user's example had "Western Blot" as an assay method. But in the given abstract, the study is about PINK1 and parkin's function. The methods might include assays for ubiquitination, maybe using HEK293 cells. But the abstract doesn't mention cell lines or specific methods. Therefore, the Material Source is N.D., and the assay method is N.D. But the user wants the approved assay to be whether the method is generally used. Since the study is about phosphorylation and ubiquitination, which are common in PD research, maybe the approved assay is yes. But the literature doesn't specify, so I'll have to use N.D.

I think the key is to follow the structure strictly. Since the variants are not specified, they are N.D. The disease is PD with the MONDO term. The experiment methods are not detailed, so most fields are N.D. except for the approved assay, which might be yes if the method is standard, but the user might not have that info. So, I'll proceed with N.D. for all except the disease.
</think>

{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "PD-linked pathogenic PINK1 mutations"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0005117"
  },
  "Experiment Method": [
    {
      "Assay Method": "N.D.",
      "Material used": {
        "Material Source": "N.D.",
        "Material Name": "N.D.",
        "Description": "N.D."
      },
      "Readout type": "N.D.",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "N.D."
      }
    }
  ]
}